Skip to main content

Advertisement

SpringerLink
Log in

IVIG therapy in neurological disorders of childhood

  • Published:
Journal of Neurology Aims and scope Submit manuscript

An Erratum to this article was published on 01 February 2008

Abstract

There is growing evidence that intravenous immunoglobulins (IVIG) are effective in some neuroimmunological disorders of childhood. This short review summarizes the evidence-based indications and recommendations of IVIG therapy in these disorders. Despite considerable efforts to define the role and mechanisms of IVIG, more clinical studies are needed to further explore the therapeutic potential of IVIG in childhood diseases of the nervous system and muscle.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abd-Allah SA, Jansen PW, Ashwal S, Perkin RM (1997) Intravenous immunoglobulin as therapy for pediatric Guillain-Barré syndrome. J Child Neurol 12:376–380

    PubMed  CAS  Google Scholar 

  2. Achiron A et al. (1998) Intravenous immunoglobulin treatment in multiple sclerosis: effect on relapses. Neurology 50:398–402

    PubMed  CAS  Google Scholar 

  3. Achiron A et al. (2004) Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Arch Neurol 61:1515–1520

    Article  PubMed  Google Scholar 

  4. Al-Mayouf SM, Laxer RM, Schneider R, Silverman ED, Feldman BM (2000) Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety. J Rheumatol 27:2498–2503

    PubMed  CAS  Google Scholar 

  5. Andrews PI (2004) Autoimmune myasthenia gravis in childhood. Semin Neurol 24:101–110

    Article  PubMed  CAS  Google Scholar 

  6. Bataller L, Graus F, Saiz A, Vilchez JJ; Spanish Opsoclonus-Myoclonus Study Group (2001) Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain 124:437–443

    Article  PubMed  CAS  Google Scholar 

  7. Bien CG, Granata T, Antozzi C, Cross JH, Dulac O, Kurthen M, Lassmann H, Mantegazza R, Villemure JG, Spreafico R, Elger CE (2005) Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 128:454–471

    Article  PubMed  CAS  Google Scholar 

  8. Borgna-Pignatti C, Balter R, Marradi P, Colamaria V (1996) Treatment with intravenously administered immunoglobulins of the neuroblastoma-associated opsoclonus-myoclonus. J Pediatr 129:179–180

    PubMed  CAS  Google Scholar 

  9. Connolly AM (2001) Chronic inflammatory demyelinating polyneuropathy in childhood. Pediatr Neurol 24:177–182

    Article  PubMed  CAS  Google Scholar 

  10. Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 291:2367–2375

    Article  PubMed  CAS  Google Scholar 

  11. Eiris J, del Rio M, Castro-Gago M (1996) Immune globulin G for treatment of opsoclonus-polymyoclonus syndrome. J Pediatr 129:175

    PubMed  CAS  Google Scholar 

  12. Fazekas F et al. (1997) Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing—remitting multiple sclerosis. Lancet 349:589–593

    Article  PubMed  CAS  Google Scholar 

  13. Freeman JM (2005) Rasmussen’s syndrome: progressive autoimmune multi-focal encephalopathy. Pediatr Neurol 32:295–299

    Article  PubMed  Google Scholar 

  14. Gajdos P, Chevret S, Toyka K (2003) Intravenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev: CD002277

    Google Scholar 

  15. Gajdos P, Tranchant C, Clair B, Bolgert F, Eymard B, Stojkovic T, Attarian S, Chevret S; Myasthenia Gravis Clinical Study Group (2005) Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial. Arch Neurol 62:1689–1693

    Article  PubMed  Google Scholar 

  16. Ghezzi A, Amato MP, Capobianco M, Gallo P, Marrosu G, Martinelli V, Milani N, Milanese C, Moiola L, Patti F, Pilato V, Pozzilli C, Trojano M, Zaffaroni M, Comi G; Immunomodulatory Treatment of Early onset MS Group (2005) Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study. Mult Scler 11:420–424

    Article  PubMed  CAS  Google Scholar 

  17. Glatz K, Meinck HM, Wildemann B (2003) Parainfectious opsoclonus-myoclonus syndrome: high dose intravenous immunoglobulins are effective. J Neurol Neurosurg Psychiatry 74:279–280

    Article  PubMed  CAS  Google Scholar 

  18. Granata T, Fusco L, Gobbi G, Freri E, Ragona F, Broggi G, Mantegazza R, Giordano L, Villani F, Capovilla G, Vigevano F, Bernardina BD, Spreafico R,Antozzi C (2003) Experience with immunomodulatory treatments in Rasmussen’s encephalitis. Neurology 61:1807–1810

    PubMed  CAS  Google Scholar 

  19. Gurses N, Uysal S, Cetinkaya F, Islek I, Kalayci AG (1995) Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome. Scand J Infect Dis 27:241–243

    PubMed  CAS  Google Scholar 

  20. Hattori N, Ichimura M, Aoki S, Nagamatsu M, Yasuda T, Kumazawa K, Yamamoto K, Mitsuma T, Sobue G (1998) Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood. J Neurol Sci 154:66–71

    Article  PubMed  CAS  Google Scholar 

  21. Illa I (2005) IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status. J Neurol 252(Suppl 1):I14–I18

    Article  PubMed  CAS  Google Scholar 

  22. Jones HR (1996) Childhood Guillain-Barre syndrome: clinical presentation, diagnosis, and therapy. J Child Neurol 11:4–12

    PubMed  CAS  Google Scholar 

  23. Kanra G, Ozon A, Vajsar J, Castagna L, Secmeer G, Topaloglu H (1997) Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome. Eur J Paediatr Neurol 1:7–12

    Article  PubMed  CAS  Google Scholar 

  24. Korinthenberg R, Monting JS (1996) Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study. Arch Dis Child 74:281–287

    PubMed  CAS  Google Scholar 

  25. Korinthenberg R (1999) Chronic inflammatory demyelinating polyradiculoneuropathy in children and their response to treatment. Neuropediatrics 30:190–196

    Article  PubMed  CAS  Google Scholar 

  26. Korinthenberg R, Schessl J, Kirschner J, Monting JS (2005) Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barre syndrome: a randomized trial. Pediatrics 116:8–14

    Article  PubMed  Google Scholar 

  27. Lang BA, Laxer RM, Murphy G, Silverman ED, Roifman CM (1991) Treatment of dermatomyositis with intravenous gammaglobulin. Am J Med 91:169–172

    Article  PubMed  CAS  Google Scholar 

  28. Leake JA, Albani S, Kao AS, Senac MO, Billman GF, Nespeca MP, Paulino AD, Quintela ER, Sawyer MH, Bradley JS (2004) Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 23:756–764

    PubMed  Google Scholar 

  29. Lewanska M, Siger-Zajdel M, and K Selmaj K (2002) No difference in efficacy of two different doses of intravenous immunoglobulins in MS: clinical and MRI assessment. Eur J Neurol 9:565–572

    Article  PubMed  CAS  Google Scholar 

  30. Menge T, Hemmer B, Nessler S, Wiendl H, Neuhaus O, Hartung HP, Kieseier BC, Stuve O (2005) Acute disseminated encephalomyelitis: an update. Arch Neurol 62:1673–1680

    Article  PubMed  Google Scholar 

  31. Mikaeloff Y, Moreau T, Debouverie M, Pelletier J, Lebrun C, Gout O, Pedespan JM, Van Hulle C, Vermersch P, Ponsot G (2001) Interferon-beta treatment in patients with childhood-onset multiple sclerosis. J Pediatr 139:443–446

    Article  PubMed  CAS  Google Scholar 

  32. Mitchell WG, Davalos-Gonzalez Y, Brumm VL, Aller SK, Burger E, Turkel SB, Borchert MS, Hollar S, Padilla S (2002) Opsoclonus-ataxia caused by childhood neuroblastoma: developmental and neurologic sequelae. Pediatrics 109:86–98

    Article  PubMed  Google Scholar 

  33. Murthy SN, Faden HS, Cohen ME, Bakshi R (2002) Acute disseminated encephalomyelitis in children. Pediatrics 110:e21

    Article  PubMed  Google Scholar 

  34. Nevo Y, Pestronk A, Kornberg AJ, Connolly AM, Yee WC, Iqbal I, Shield LK (1996) Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up. Neurology 47:98–102

    PubMed  CAS  Google Scholar 

  35. Paradiso G, Tripoli J, Galicchio S, Fejerman N (1999) Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barré syndrome: a reappraisal. Ann Neurol 46:701–707

    Article  PubMed  CAS  Google Scholar 

  36. Pless M, Ronthal M (1996) Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin. Neurology 46:583–584

    PubMed  CAS  Google Scholar 

  37. Pohl D, Rostasy K, Gartner J, Hanefeld F (2005) Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a. Neurology 64:888–890

    PubMed  CAS  Google Scholar 

  38. Reisin RC, Pociecha J, Rodriguez E, Massaro ME, Arroyo HA, Fejerman N (1996) Severe Guillain-Barré syndrome in childhood treated with human immune globulin. Pediatr Neurol 14:308–312

    Article  PubMed  CAS  Google Scholar 

  39. Rieckmann P et al. (2004) Escalating immunotherapy for multiple sclerosis—new aspects and practical application. J Neurol 251:1329–1339

    Article  PubMed  CAS  Google Scholar 

  40. Ryan MM, Grattan-Smith PJ, Procopis PG, Morgan G, Ouvrier RA (2000) Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome. Neuromuscul Disord 10:398–406

    Article  PubMed  CAS  Google Scholar 

  41. Ryan MM (2005) Guillain-Barré syndrome in childhood. J Paediatr Child Health 41:237–241

    Article  PubMed  Google Scholar 

  42. Sansome A, Dubowitz V (1995) Intravenous immunoglobulin in juvenile dermatomyositis—four year review of nine cases. Arch Dis Child 72:25–28

    Article  PubMed  CAS  Google Scholar 

  43. Selcen D, Dabrowski ER, Michon AM, Nigro MA (2000) High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis. Pediatr Neurol 22:40–43

    Article  PubMed  CAS  Google Scholar 

  44. Shahar E, Shorer Z, Roifman CM, Levi Y, Brand N, Ravid S, Murphy EG (1997) Immune globulins are effective in severe pediatric Guillain-Barré syndrome. Pediatr Neurol 16:32–36

    Article  PubMed  CAS  Google Scholar 

  45. Shahar E, Andraus J, Savitzki D, Pilar G, Zelnik N (2002) Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins. J Child Neurol 17:810–814

    PubMed  Google Scholar 

  46. Shahar E, Leiderman M (2003) Outcome of severe Guillain-Barré syndrome in children: comparison between untreated cases versus gamma-globulin therapy. Clin Neuropharmacol 26:84–87

    Article  PubMed  CAS  Google Scholar 

  47. Simmons Z, Wald JJ, Albers JW (1997) Chronic inflammatory demyelinating polyradiculoneuropathy in children: I Presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults. Muscle Nerve 20:1008–1015

    Article  PubMed  CAS  Google Scholar 

  48. Simmons Z, Wald JJ, Albers JW (1997) Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults. Muscle Nerve 20:1569–1575

    Article  PubMed  CAS  Google Scholar 

  49. Simone IL, Carrara D, Tortorella C, Liguori M, Lepore V, Pellegrini F, Bellacosa A, Ceccarelli A, Pavone I, Livrea P (2002) Course and prognosis in early-onset MS: comparison with adultonset forms. Neurology 59:1922–1928

    PubMed  CAS  Google Scholar 

  50. Singhi SC, Jayshree M, Singhi P, Banerjee S, Prabhakar S (1999) Intravenous immunoglobulin in very severe childhood Guillain-Barré syndrome. Ann Trop Paediatr 19:167–174

    Article  PubMed  CAS  Google Scholar 

  51. Sladky JT (2004) Guillain-Barré syndrome in children. J Child Neurol 19:191–200

    PubMed  Google Scholar 

  52. Sørensen P et al. (1998) Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis. Neurology 50:1273–1281

    PubMed  Google Scholar 

  53. Sørensen P, Fazekas F, Lee M (2002) Intravenous immunoglobulin G for the treatment of relapsing-remitting multiple sclerosis: a meta-analysis. Eur J Neurol 9:557–563

    Article  PubMed  Google Scholar 

  54. Stangel M et al. (1997) Side effects of high-dose intravenous immunoglobulins. Clin Neuropharmacol 20:385–393

    PubMed  CAS  Google Scholar 

  55. Stangel M et al. (2003) Side effects of immunoglobulins in neurological autoimmune disorders—a prospective study. J Neurol 250:818–821

    Article  PubMed  Google Scholar 

  56. Stangel M, Gold R (2004) Use of IV immunoglobulins in neurology. Evidence-based consensus. Nervenarzt 75:801–816 (in German)

    Article  PubMed  CAS  Google Scholar 

  57. Tate ED, Allison TJ, Pranzatelli MR, Verhulst SJ (2005) Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs 22:8–19

    Article  PubMed  Google Scholar 

  58. Vajsar J, Sloane A, Wood E, Murphy EG (1994) Plasmapheresis vs intravenous immunoglobulin treatment in childhood Guillain-Barre syndrome. Arch Pediatr Adolesc Med 148:1210–1212

    PubMed  CAS  Google Scholar 

  59. Vedanarayanan VV, Kandt RS, Lewis DV Jr, DeLong GR (1991) Chronic inflammatory demyelinating polyradiculoneuropathy of childhood: treatment with high-dose intravenous immunoglobulin. Neurology 41:828–830

    PubMed  CAS  Google Scholar 

  60. Waubant E, Hietpas J, Stewart T, Dyme Z, Herbert J, Lacy J, Miller C, Rensel M, Schwid S, Goodkin D (2001) Interferon beta-1a in children with multiple sclerosis is well tolerated. Neuropediatrics 32:211–213

    Article  PubMed  CAS  Google Scholar 

  61. Yata J, Nihei K, Ohya T, Hirano Y, Momoi M, Maekawa K, Sakakihara Y; Study Group for Pediatric Guillain-Barré Syndrome (2003) High-dose immunoglobulin therapy for Guillain-Barré syndrome in Japanese children. Pediatr Int 45:543–549

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Medical University Graz, Auenbruggerplatz 22, 8036, Graz, Austria

    Juan J. Archelos & Franz Fazekas

Authors
  1. Juan J. Archelos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Franz Fazekas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Juan J. Archelos.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s00415-008-0881-z.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Archelos, J.J., Fazekas, F. IVIG therapy in neurological disorders of childhood. J Neurol 253 (Suppl 5), v80–v86 (2006). https://doi.org/10.1007/s00415-006-5014-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-5014-y

Key words

Search

Navigation